Slow channel inhibitor effects on brain function: tolerance to severe hypoxia in the rat.
1. The protective effects of ten slow channel inhibitor drugs against severe progressive hypoxia were investigated in rats breathing spontaneously during light anaesthesia. Respiration, heart rate, electrocorticogram (ECoG) and/or electroencephalogram (EEG) were recorded. 2. Tolerance times were monitored from hypoxia onset until cessation of respiration, ECoG, EEG synchronization, and 'background-EEG'. Drugs were administered i.v. 5 min before the onset of hypoxia. 3. Verapamil, gallopamil, and nimodipine resulted in a significant increase of tolerance times; fendiline and bepridil showed a small increase (not significant); bencyclan and prenylamine were ineffective; cinnarizine and diltiazem slightly reduced tolerance times as did flunarizine at low doses. 4. At protective doses, verapamil, gallopamil, and nimodipine significantly raised the respiration rate but had little or no cardiac depressor effects. Bencyclan showed ventilatory drive but cardiocirculatory depression. A clear-cut ventilatory drive did not occur with the other ineffective slow channel inhibitors. 5. It is suggested that the protective actions observed were not due to slow channel inhibition per se, nor to spasmolytic potency or increased cerebral blood flow. Ventilatory drive associated with other cardiopulmonary actions which secondarily raise the brain oxygen supply are likely to be responsible for this effect.
Cartheuser
C F
CF
Zentrum Physiologie, Medizinische Hochschule Hannover, FRG.
D000818:Animals; D001537:Bencyclane / Q000494:pharmacology; D015764:Bepridil; D001921:Brain / Q000187:drug effects / Q000503:physiopathology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002936:Cinnarizine / Q000494:pharmacology; D004110:Diltiazem / Q000494:pharmacology; D004569:Electroencephalography; D005275:Fendiline / Q000494:pharmacology; D005444:Flunarizine / Q000494:pharmacology; D005711:Gallopamil / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D000860:Hypoxia / Q000503:physiopathology*; D009553:Nimodipine / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012119:Respiration / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D011759:Pyrrolidines; D005711:Gallopamil; D002936:Cinnarizine; D009553:Nimodipine; D001537:Bencyclane; D015764:Bepridil; D014700:Verapamil; D004110:Diltiazem; D011299:Prenylamine; D005444:Flunarizine; D005275:Fendiline